Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial

Authors

  • Katarina Y. Blom Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Physiotherapy Cancer, Karolinska University Hospital, Stockholm, Sweden
  • Karin I. Johansson Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden
  • Lena B. Nilsson-Wikmar Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden
  • Christina B. Brogårdh Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, Skåne University Hospital, Lund, Sweden

DOI:

https://doi.org/10.1080/0284186X.2022.2081932

Keywords:

Breast cancer, arm lymphedema, early intervention, compression garment

Abstract

Background

Early diagnosis and compression treatment are important to prevent progression in breast cancer-related arm lymphedema (BCRAL). However, some mild BCRAL can be reversible, and therefore, compression treatment may not be needed. The aim of this study was to investigate the proportion of women with mild BCRAL showing progression/no progression of lymphedema after treatment with or without compression garments, differences in changes of lymphedema relative volume (LRV), local tissue water and subjective symptoms during 6 months. Also, adherence to self-care was examined.

Material and methods

Seventy-five women diagnosed with mild BCRAL were randomized to a compression group (CG) or noncompression group (NCG). Both groups received self-care instructions, and the CG were treated with a standard compression garment (ccl 1). Women in the NCG who progressed in LRV ≥2%, or exceeded 10% dropped out, and received appropriate treatment. The proportion showing progression/no progression of LRV, and changes in LRV was measured by Water Displacement Method. Changes in local tissue water were measured by Tissue Dielectric Constant (TDC), subjective symptoms by Visual Analogue Scale, and self-care by a questionnaire.

Results

A smaller proportion of LRV progression was found in the CG compared to the NCG at 1, 2 and 6 months follow-up (p ≤ 0.013). At 6 months, 16% had progression of LRV in the CG, compared to 57% in the NCG, (p = 0.001). Thus, 43% in the NCG showed no progression and could manage without compression. Also, CG had a larger reduction in LRV, at all time-points (p ≤ 0.005), and in the highest TDC ratio, when same site followed, at 6 months (p = 0.025). Subjective symptoms did not differ between the groups, except at 1 month, where the CG experienced more reduced tension (p = 0.008). There were no differences in adherence to self-care.

Conclusion

Early treatment with compression garment can prevent progression in mild BCRAL. Trial registration: ISRCT nr ISRCTN51918431

Downloads

Download data is not yet available.

Downloads

Published

2022-07-03

How to Cite

Blom, K. Y., Johansson, K. I., Nilsson-Wikmar, L. B., & Brogårdh, C. B. (2022). Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial. Acta Oncologica, 61(7), 897–905. https://doi.org/10.1080/0284186X.2022.2081932